SCHEMBL8761065

SCHEMBL8761065

CCc1cn(COCC(O[SiH](C)C)C(C)(C)C)c(=S)[nH]c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8761117 0.90 UPP1 (0.36)
SCHEMBL9354282 0.79 DUT (0.39)
SCHEMBL9353754 0.76 MAPK1 (0.41)
SCHEMBL7534620 0.76 UPP1 (0.35)
SCHEMBL9353914 0.70 SIRT2 (0.37)
SCHEMBL7534083 0.70 DUT (0.56)
SCHEMBL9353732 0.70 SIRT2 (0.37)
SCHEMBL7541951 0.69 UPP1 (0.46)
SCHEMBL9357392 0.67 ALDH1A1 (0.34)
SCHEMBL8760912 0.66 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0449726-B1 Pyrimidine nucleoside derivative and antiviral agent containing the derivative as active ingredient MITSUBISHI CHEM CORP (JP) 1997-06-11 EP disclosed
US-5318972-A Active against retroviruses, human t-cell leukemia/lymphoma viruses MITSUBISHI KASEI CORPORATION (JP) 1994-06-07 US disclosed
EP-0449726-A1 Pyrimidine nucleoside derivative and antiviral agent containing the derivative as active ingredient Mitsubishi Chemical Corporation (JP) 1991-10-02 EP disclosed